MARKET

IPHYF

IPHYF

Innate Pharma Marseille
OTCPK
2.250
NaN%
Closed 09:30 08/19 EDT
OPEN
--
PREV CLOSE
2.250
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.250
52 WEEK LOW
1.580
MARKET CAP
210.83M
P/E (TTM)
-3.4927
1D
5D
1M
3M
1Y
5Y
1D
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
TipRanks · 9h ago
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
TipRanks · 5d ago
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
TipRanks · 5d ago
Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway
TipRanks · 6d ago
Leerink upgrades Innate Pharma to Outperform after lacutamab deal
TipRanks · 08/11 10:20
Innate Pharma upgraded to Outperform from Market Perform at Leerink
TipRanks · 08/11 10:15
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
TipRanks · 08/10 16:30
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
TipRanks · 08/10 09:30
More
About IPHYF
Innate Pharma SA is a France-based biopharmaceutical company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications, and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. It works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk. It also has a multi-product partnership with AstraZeneca.

Webull offers Innate Pharma SA stock information, including OTCPK: IPHYF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPHYF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPHYF stock methods without spending real money on the virtual paper trading platform.